E-LIB Suche - Ergebnisse für: Viviani, S

1

FERTILITY PRESERVATION IN ADULT LYMPHOMA PATIENTS: A CONSEN..:

Minoia, C. ; Viviani, S. ; Silvestris, E....
Hematological Oncology. 41 (2023) S2 - p. 678-679 , 2023

Link: https://doi.org/10.1002/..

2

Baseline‐PET derived metrics are the most relevant factors ..:

Zaucha, J. M. ; Picardi, M. ; Kurlapski, M....
Hematological Oncology. 41 (2023) S2 - p. 350-351 , 2023

Link: https://doi.org/10.1002/..

3

TREATMENT STRATEGIES AND PROGNOSTIC FACTORS FOR THE OUTCOME..:

Vassilakopoulos, T. P. ; Liaskas, A. ; Rizzuto, G....
Hematological Oncology. 41 (2023) S2 - p. 677-677 , 2023

Link: https://doi.org/10.1002/..

4

RADIATION FREE THERAPY OR THE INITIAL TREATMENT OF GOOD PRO..:

Gallamini, A. ; Walewski, J. ; Rambaldi, A....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

5

LATE TOXICITIES AND LONG‐TERM MONITORING IN CLASSICAL HODGK..:

Minoia, C. ; Gerardi, C. ; Allocati, E....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

6

BASELINE METABOLIC TUMOR VOLUME AND IPS PREDICT ABVD FAILUR..:

Gallamini, A ; Rambaldi, A ; Patti, C...
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

7

Joint models for a GLM-type longitudinal response and a tim..:

Viviani, S.
Journal of Applied Statistics. 46 (2019) 15 - p. 2804-2818 , 2019

Link: https://doi.org/10.1080/..

8

BRENTUXIMAB‐VEDOTIN AND BENDAMUSTINE IS A FEASIBLE AND EFFE..:

Gallamini, A. ; Schiano de Colella, J. ; Viotti, J....
Hematological Oncology. 37 (2019) S2 - p. 292-293 , 2019

Link: https://doi.org/10.1002/..

9

CONSOLIDATION RADIOTHERAPY COULD BE OMITTED IN ADVANCED HOD..:

Gallamini, A. ; Rossi, A. ; Patti, C....
Hematological Oncology. 37 (2019) S2 - p. 147-148 , 2019

Link: https://doi.org/10.1002/..

10

Treatment of classical Hodgkin lymphoma in the era of brent..:

Carella, A. M. ; Corradini, P. ; Mussetti, A....
Annals of Hematology. 97 (2018) 8 - p. 1301-1315 , 2018

Link: https://doi.org/10.1007/..

11

BRENTUXIMAB‐VEDOTIN AND BENDAMUSTINE IS A FEASIBLE AND EFFE..:

Gallamini, A. ; Bijou, F. ; Viotti, J....
Hematological Oncology. 35 (2017) S2 - p. 170-170 , 2017

Link: https://doi.org/10.1002/..

12

ALLOGENEIC TRANSPLANTATION IN HODGKIN'S LYMPHOMA AFTER A FA..:

Spina, F. ; Radice, T. ; Dalto, S....
Hematological Oncology. 35 (2017) S2 - p. 169-190 , 2017

Link: https://doi.org/10.1002/..

13

Early reduction of serum TARC levels may predict for succes..:

Guidetti, A. ; Mazzocchi, A. ; Miceli, R....
Leukemia Research. 62 (2017) - p. 91-97 , 2017

Link: https://doi.org/10.1016/..

14

Second malignancies and cardiovascular diseases in long‐ter..:

Viviani, S. ; Soldarini, M. ; Cieri, N....
Hematological Oncology. 35 (2017) S2 - p. 313-313 , 2017

Link: https://doi.org/10.1002/..

15

PD-0526: Relationship between extension of radiation fields..:

Di Russo, A. ; Viviani, S. ; Cosentino, V....
Radiotherapy and Oncology. 106 (2013) - p. S202-S203 , 2013

Link: https://doi.org/10.1016/..